한국어
English
日本語
中文(简体)
Venetoclax 100 mg Tablet (Venetoclax)
100mg
Tablet · Prescription medication
AbbVie Korea Co., Ltd.
Venetoclax is a pro-apoptotic anticancer agent used in the treatment of hematologic cancers.
MFDS ingredient code M266370
Venetoclax is a drug belonging to the antineoplastic agent class, primarily used for the treatment of specific hematologic cancers such as chronic lymphocytic leukemia. This ingredient aims to eliminate cancer cells by inhibiting proteins that help the survival of cancer cells.
Venetoclax selectively blocks the BCL-2 protein, which inhibits apoptosis in cancer cells. This promotes the process of cancer cell self-destruction and suppresses cancer progression.
Approved uses differ by product. Check each product's information for its actual use.
Venetoclax is the first oral medication that acts specifically on the BCL-2 protein. Unlike conventional anticancer agents, it directly inhibits target proteins to reduce side effects and enhance effectiveness.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
